Sandbox/001: Difference between revisions

Jump to navigation Jump to search
 
(6 intermediate revisions by the same user not shown)
Line 25: Line 25:
| align="center" style="background:#A5B2D6; width: 55px;"|'''CVP'''
| align="center" style="background:#A5B2D6; width: 55px;"|'''CVP'''
| align="center" style="background:#A5B2D6; width: 55px;"|'''SVO2'''
| align="center" style="background:#A5B2D6; width: 55px;"|'''SVO2'''
| align="center" style="background:#A5B2D6; width: 55px;"|'''Feature'''
|-
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC; width: 80px;" align=center rowspan=3 |'''Cardiogenic'''|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC; width: 200px;" |'''[[Ventricular septal defect|Acute Ventricular Septal Defect]]'''|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓↓|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↑|| style="font-size: 90%; padding: 0 5px; background:#DCDCDC;" align=center |↑↑|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑ — ↑↑
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC; width: 80px;" align=center rowspan=3 |'''Cardiogenic'''|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC; width: 200px;" |'''[[Ventricular septal defect|Acute Ventricular Septal Defect]]'''|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓↓|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↑|| style="font-size: 90%; padding: 0 5px; background:#DCDCDC;" align=center |↑↑|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑ — ↑↑ || style="font-size: 90%; padding: 0 5px; background: #DCDCDC; width: 200px;" rowspan=3 | ↑ JVP, hepatojugular reflux, S3, S4, murmurs
|-
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" |'''[[Mitral regurgitation|Acute Mitral Regurgitation]]'''|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓↓|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑↑|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑ — ↑↑|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" |'''[[Mitral regurgitation|Acute Mitral Regurgitation]]'''|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓↓|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑↑|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑ — ↑↑|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓
Line 40: Line 41:
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" |'''[[Anaphylactic shock|Anaphylactic Shock]]'''|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↑↑|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓ — ↓↓|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↓|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↓|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑ — ↑↑
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" |'''[[Anaphylactic shock|Anaphylactic Shock]]'''|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↑↑|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓ — ↓↓|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↓|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↓|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑ — ↑↑
|-
|-
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" rowspan=1 align=center |'''Hypovolemic'''|| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" |'''[[Volume depletion|Volume Depletion]]'''|| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓↓||style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↑|| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓↓|| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓↓|| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" rowspan=1 align=center |'''Hypovolemic'''|| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" |'''[[Volume depletion|Volume Depletion]]'''|| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓↓||style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↑|| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓↓|| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓↓|| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓|| ↓ JVP
|-
|-
|}
|}
Line 68: Line 69:
{{Family tree|border=2|boxstyle=background: WhiteSmoke;| | | | | | | | | | | | | |!| | | | | | | | | | | | | | |}}
{{Family tree|border=2|boxstyle=background: WhiteSmoke;| | | | | | | | | | | | | |!| | | | | | | | | | | | | | |}}
{{Family tree|border=2|boxstyle=background: WhiteSmoke;| | | | | | | | | | | | | C01 | | | | | | | | | | | | | |C01=
{{Family tree|border=2|boxstyle=background: WhiteSmoke;| | | | | | | | | | | | | C01 | | | | | | | | | | | | | |C01=
<div style="text-align: left; height: 300px; width: 200px; padding: 5px;">
<div style="text-align: left; height: 520px; width: 200px; padding: 5px;">
'''Resuscitation''' <BR>
'''Resuscitation''' <BR>
----
----
❑ 0.5—1 L every 10—15 minutes<sup>†</sup> <BR>
❑ ± Morphine 2—4 mg boluses <BR>
❑ Ventilatory support <BR>
❑ Ventilatory support <BR>
 
'''Labs & Imaging''' <BR>
0.5—1 L every 10—15 minutes<sup></sup> <BR>
----
Morphine 2—4 mg boluses<BR>
❑ CBC/DC/SMA-7/PT/PTT <BR>
❑ Arterial blood gas <BR>
❑ Lactate <BR>
❑ ECG <BR>
❑ CXR <BR>
Echocardiography <BR>
❑ CXR <BR>
❑ Central venous catheter <BR>
Pulmonary artery catheter <BR>
'''Immediate Goals''' <BR>
'''Immediate Goals''' <BR>
----
----
Line 91: Line 102:
{{Family tree|border=2|boxstyle=background: WhiteSmoke;| | | | | | | | | | | | | D01 | | | | | | | | | | | | | |D01=
{{Family tree|border=2|boxstyle=background: WhiteSmoke;| | | | | | | | | | | | | D01 | | | | | | | | | | | | | |D01=
<div style="text-align: left; height: 130px; width: 200px;">
<div style="text-align: left; height: 130px; width: 200px;">
'''Labs & Imaging''' <BR>
----
❑ CBC/DC/SMA-7/PT/PTT <BR>
❑ Arterial blood gas <BR>
❑ Lactate <BR>
❑ ECG <BR>
❑ Echocardiography
</div>}}
</div>}}
{{Family tree/end}}
{{Family tree/end}}

Latest revision as of 16:27, 5 March 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: Circulatory shock

Definition

Shock is the clinical expression of circulatory failure that results in inadequate cellular oxygen utilization.[1]

Causes

Shock is a life-threatening condition and must be treated as such irrespective of the causes.


Classification

Hemodynamic Profiles of Shock[2]
Type of Shock CO SVR PCWP CVP SVO2 Feature
Cardiogenic Acute Ventricular Septal Defect ↓↓ N — ↑ ↑↑ ↑ — ↑↑ ↑ JVP, hepatojugular reflux, S3, S4, murmurs
Acute Mitral Regurgitation ↓↓ ↑↑ ↑ — ↑↑
Myocardial Infarction ↓↓ ↑↑ ↑↑
Obstructive Pulmonary Embolism ↓↓ N — ↓ ↑↑
Cardiac Tamponade ↓ — ↓↓ ↑↑ ↑↑
Distributive Septic Shock N — ↑↑ ↓ — ↓↓ N — ↓ N — ↓ ↑ — ↑↑
Anaphylactic Shock N — ↑↑ ↓ — ↓↓ N — ↓ N — ↓ ↑ — ↑↑
Hypovolemic Volume Depletion ↓↓ ↓↓ ↓↓ ↓ JVP


[3]

Management

 
 
 
 
 
 
 
 
 
 
 
 

Symptoms & Signs


❑ Altered mental status
❑ Cyanosis
❑ Hypotension (MAP <60 mmHg)
❑ Oliguria (<0.5 mL/kg/h)
❑ Tachycardia
❑ Tachypnea

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Shock

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Resuscitation


❑ 0.5—1 L every 10—15 minutes
❑ ± Morphine 2—4 mg boluses
❑ Ventilatory support
Labs & Imaging


❑ CBC/DC/SMA-7/PT/PTT
❑ Arterial blood gas
❑ Lactate
❑ ECG
❑ CXR
❑ Echocardiography
❑ CXR
❑ Central venous catheter
❑ Pulmonary artery catheter
Immediate Goals


❑ MAP >60—65 mmHg
❑ CVP 8—12 mmHg
❑ PCWP 12—15 mmHg
❑ CI >2.1 L/min/m2
❑ Hemoglobin >7—9 g/dL
❑ SaO2 >90%—92%
❑ MVO2 >60%
❑ SCVO2 >70%
❑ Lactate <2.2 mM/L
❑ Urine output >0.5 mL/kg/h

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

100—200 mL boluses for cardiogenic shock

References

  1. Vincent, JL.; De Backer, D. (2013). "Circulatory shock". N Engl J Med. 369 (18): 1726–34. doi:10.1056/NEJMra1208943. PMID 24171518. Unknown parameter |month= ignored (help)
  2. Parrillo, Joseph E.; Ayres, Stephen M. (1984). Major issues in critical care medicin. Baltimore: William Wilkins. ISBN 0-683-06754-0.
  3. Weil, Max Harry; Shubin, Herbert (1967). Diagnosis and Treatment of Shock. Williams & Wilkins. ISBN 1125885874.